ArticleFrontiers in immunology2021

Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition.

Oladapo O Yeku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.